Saturday March 23, 2019

A Nap During The Day Can Lower High BP: Study

Further research is needed to validate these findings, the team noted

0
//
blood pressure
BP-monitoring machine. Pixabay

Want to lower your high blood pressure? Taking a nap during the day may help reduce hypertension levels, besides increasing your energy levels and improving mood, finds a study.

The findings showed that taking a nap during the day was associated with an average 5 mm Hg drop in blood pressure.

In addition, for every 60 minutes of mid-day sleep, 24-hour average systolic (top number) blood pressure decreased by 3 mm Hg.

“Mid-day sleep appears to lower blood pressure levels at the same magnitude as other lifestyle changes,” said Manolis Kallistratos, cardiologist at the Asklepieion General Hospital in Voula in Greece.

“These findings are important because a drop in blood pressure as small as 2 mm Hg can reduce the risk of cardiovascular events such as heart attack by up to 10 per cent,” said Kallistratos.

Blood Pressure
Mid-day nap can lower high BP. Flickr

Moreover, people who slept during the day had more favourable blood pressure numbers readings (128.7/76.2 versus 134.5/79.5 mm Hg) compared with those who did not.

“We obviously don’t want to encourage people to sleep for hours on end during the day, but on the other hand, they shouldn’t feel guilty if they can take a short nap, given the potential health benefits,” said Kallistratos.

The results will be presented at the American College of Cardiology’s 68th Annual Scientific Session in New Orleans.

Also Read- 2.6 mn Children at Risk in Philippines Measles Outbreak

For the study, the team included 212 people aged 62 years on average with a mean blood pressure of 129.9 mm Hg.

Further research is needed to validate these findings, the team noted. (IANS)

Next Story

Shortage Of Blood Pressure Drugs After Recall: FDA

The agency said that it determined that the impurities "may be generated when specific chemicals and reaction conditions are present in the manufacturing process"

0
Blood Pressure, Drugs
A man has his blood pressure checked at a clinic in Wise, Virginia, July 22, 2017. VOA

Additional shortages of blood pressure drugs in the United States are possible following recent recalls related to traces of a probable carcinogen found in some versions a particular class of hypertension medicines, the U.S. Food and Drug Administration said Friday.

The drugs, including valsartan, belong to a class of widely-used medicines for treating high blood pressure called angiotensin II receptor blockers, or ARBs. Valsartan is the generic of Novartis’ Diovan.

The FDA also said it may have identified the root cause of the potentially cancer-causing impurities but that it is still investigating.

The recalls began last summer after the FDA was informed that ingredients used by Chinese manufacturer Zhejiang Huahai Pharmaceuticals Co (Huahai) to produce valsartan contained the impurities. The FDA later halted all imports from one of Huahai’s factories.

Drugs
Some generic versions of other ARBS, such as losartan and irbesartan, have also been recalled.

Other manufacturers have also had to recall valsartan after the impurities were found in their versions of the drug.

It is currently listed as in shortage by the FDA.

Generic drugs

Some generic versions of other ARBS, such as losartan and irbesartan, have also been recalled. The most recent recall was announced earlier this week.

Also Read: New Wearable Patch That Helps in Monitoring Blood Pressure

The agency said that it determined that the impurities “may be generated when specific chemicals and reaction conditions are present in the manufacturing process” and “may also result from the reuse of materials, such as solvents.”

The reuse of solvents is an accepted practice in the industry, but manufacturers are generally expected to ensure that reused materials meet certain safety standards. (VOA)